News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
383,780 Results
Type
Article (33450)
Company Profile (63)
Press Release (350267)
Section
Business (102513)
Career Advice (2559)
Deals (18528)
Drug Delivery (93)
Drug Development (50222)
Employer Resources (154)
FDA (9447)
Job Trends (9599)
News (184352)
Policy (19461)
Tag
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (5)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Genetown Elite (1)
Academia (2105)
Accelerated approval (1)
Adcomms (20)
Allergies (61)
Alliances (25662)
ALS (65)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (89)
Approvals (9444)
Artificial intelligence (147)
Autoimmune disease (9)
Automation (6)
Bankruptcy (134)
Best Places to Work (7866)
BIOSECURE Act (9)
Biosimilars (70)
Biotechnology (44)
Bladder cancer (35)
Brain cancer (20)
Breast cancer (193)
Cancer (1368)
Cardiovascular disease (121)
Career advice (2152)
Career pathing (31)
CAR-T (112)
Cell therapy (271)
Cervical cancer (13)
Clinical research (40549)
Collaboration (445)
Compensation (276)
Complete response letters (17)
COVID-19 (2095)
CRISPR (32)
C-suite (95)
Cystic fibrosis (62)
Data (1374)
Decentralized trials (1)
Denatured (6)
Depression (34)
Diabetes (189)
Diagnostics (3754)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (72)
Drug pricing (83)
Drug shortages (22)
Duchenne muscular dystrophy (62)
Earnings (48057)
Editorial (35)
Employer branding (18)
Employer resources (134)
Events (58482)
Executive appointments (284)
FDA (10136)
Featured Employer (24)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (369)
Gene editing (77)
Generative AI (16)
Gene therapy (235)
GLP-1 (509)
Government (3363)
Grass and pollen (2)
Guidances (28)
Healthcare (12222)
Huntington's disease (15)
IgA nephropathy (15)
Immunology and inflammation (69)
Indications (19)
Infectious disease (2193)
Inflammatory bowel disease (84)
Inflation Reduction Act (7)
Influenza (36)
Intellectual property (39)
Interviews (463)
IPO (9281)
IRA (38)
Job creations (2078)
Job search strategy (1777)
Kidney cancer (7)
Labor market (21)
Layoffs (347)
Leadership (20)
Legal (4236)
Liver cancer (44)
Lung cancer (212)
Lymphoma (107)
Machine learning (4)
Management (53)
Manufacturing (170)
MASH (55)
Medical device (7604)
Medtech (7605)
Mergers & acquisitions (9544)
Metabolic disorders (493)
Multiple sclerosis (57)
NASH (21)
Neurodegenerative disease (60)
Neuropsychiatric disorders (23)
Neuroscience (1321)
NextGen: Class of 2025 (4331)
Non-profit (3355)
Northern California (1397)
Now hiring (10)
Obesity (253)
Opinion (226)
Ovarian cancer (61)
Pain (49)
Pancreatic cancer (57)
Parkinson's disease (100)
Partnered (11)
Patents (107)
Patient recruitment (56)
Peanut (37)
People (22047)
Pharmaceutical (21)
Pharmacy benefit managers (12)
Phase I (11601)
Phase II (17632)
Phase III (15004)
Pipeline (701)
Podcasts (62)
Policy (87)
Postmarket research (1695)
Preclinical (4848)
Press Release (34)
Prostate cancer (60)
Psychedelics (24)
Radiopharmaceuticals (125)
Rare diseases (279)
Real estate (3169)
Recruiting (64)
Regulatory (13229)
Reports (25)
Research institute (1741)
Resumes & cover letters (429)
Rett syndrome (3)
RNA editing (4)
RSV (34)
Schizophrenia (52)
Series A (62)
Series B (38)
Service/supplier (5)
Sickle cell disease (41)
Southern California (1283)
Special edition (10)
Spinal muscular atrophy (125)
Sponsored (26)
Startups (1947)
State (1)
Stomach cancer (8)
Supply chain (33)
The Weekly (53)
United States (12354)
Vaccines (529)
Venture capitalists (27)
Webinars (6)
Weight loss (191)
Women's health (18)
Worklife (18)
Date
Today (141)
Last 7 days (457)
Last 30 days (1735)
Last 365 days (20586)
2025 (4917)
2024 (21123)
2023 (23711)
2022 (30573)
2021 (34411)
2020 (33020)
2019 (29322)
2018 (22556)
2017 (18893)
2016 (18895)
2015 (21432)
2014 (15556)
2013 (12830)
2012 (13513)
2011 (14252)
2010 (12202)
Location
Africa (644)
Alabama (30)
Alaska (3)
Arizona (113)
Arkansas (8)
Asia (23157)
Australia (3931)
California (3210)
Canada (1182)
China (294)
Colorado (148)
Connecticut (156)
Delaware (91)
Europe (53009)
Florida (503)
Georgia (117)
Idaho (33)
Illinois (319)
India (11)
Indiana (193)
Iowa (2)
Japan (100)
Kansas (68)
Kentucky (12)
Louisiana (1)
Maine (26)
Maryland (492)
Massachusetts (2319)
Michigan (109)
Minnesota (185)
Mississippi (2)
Missouri (43)
Montana (10)
Nebraska (12)
Nevada (33)
New Hampshire (41)
New Jersey (1022)
New Mexico (11)
New York (985)
North Carolina (569)
North Dakota (3)
Northern California (1397)
Ohio (95)
Oklahoma (6)
Oregon (16)
Pennsylvania (738)
Puerto Rico (5)
Rhode Island (19)
South America (906)
South Carolina (8)
South Dakota (1)
Southern California (1283)
Tennessee (56)
Texas (449)
Utah (109)
Virginia (74)
Washington D.C. (31)
Washington State (254)
West Virginia (3)
Wisconsin (20)
383,780 Results for "one drop".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Autoimmune disease
Immunovant Will Drop One Myasthenia Gravis Asset, Continuing to Favor Another
Analysts were happy with batoclimab’s performance in the chronic autoimmune disorder, but Immunovant said it will continue to focus on another next-gen asset for the indication.
March 19, 2025
·
1 min read
·
Annalee Armstrong
Weight loss
Kallyope Discreetly Drops Disappointing Data for Oral Obesity Candidate
While Kallyope’s drugs are mechanistically unique, the biotech is competing in a crowded space, with other therapies that appear to elicit superior weight-loss.
February 27, 2025
·
2 min read
·
Tristan Manalac
Compensation
Average Life Sciences Salaries Up 9% in 2024, but Bonuses and Equity Values Drop:
BioSpace
Report
The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.
March 25, 2025
·
3 min read
·
Angela Gabriel
Cardiovascular disease
Mineralys’ Hypertension Drug Drops Blood Pressure in Phase II/III, Setting Up Market Clash
Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in a pair of clinical trials.
March 10, 2025
·
2 min read
·
Dan Samorodnitsky
Vaccines
Good Day for Gardasil as Merck Wins Safety Suit, Drops $1B for Manufacturing Push
According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of its HPV vaccine Gardasil to patients and prescribers.
March 12, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Allakos Will Axe 75% of Workforce, Drop Hives Candidate
Following disappointing clinical trial results for AK006, Allakos will cut its workforce down to under 20 employees as it explores strategic alternatives.
January 27, 2025
·
1 min read
·
Angela Gabriel
Business
Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings
Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while responding positively to the announcement that Julie Kim will take the helm of the Japanese giant in 2026.
January 30, 2025
·
1 min read
·
Dan Samorodnitsky
Weight loss
BioAge Drops Lead Obesity Asset Months After IPO
It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after the molecule caused liver-based side effects.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
BIOSECURE Act
WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms
With the BIOSECURE Act likely to be voted on in Congress this year, WuXi AppTec’s U.S. revenue dropped 1.2% in the first half of 2024 while the Chinese company increased its lobbying efforts.
July 29, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
February 27, 2025
·
1 min read
1 of 38,378
Next
